Lv61
2410 积分 2022-05-09 加入
Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices
2小时前
已关闭
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
1个月前
已完结
Recent advances in therapeutic targeting of the KRAS pathway in cancer
2个月前
已完结
Combinatorial strategies to target RAS-driven cancers
2个月前
已完结
Efficacy of Pemafibrate Versus Fenofibrate Administration on Serum Lipid Levels in Patients with Dyslipidemia: Network Meta-Analysis and Systematic Review
2个月前
已完结
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)
4个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
4个月前
已完结
The KRAS signaling pathway's impact on the characteristics of pancreatic cancer cells
5个月前
已完结
Unlocking the promise of RAS inhibition in pancreatic cancer
5个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
5个月前
已完结
皖公网安备34019202002308
